FDA Approves Bevacizumab for Second-Line Combinations
Bevacizumab is now approved by the Food and Drug Administration for use in combination with fluoropyrimidine-irinotecan-based or fluoropyrimidine-oxaliplatin-based chemotherapy for metastatic colorectal...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news
More News: Avastin | Cancer & Oncology | Chemotherapy | Eloxatin | Food and Drug Administration (FDA)